Click Therapeutics

Digital Therapeutics

Click Therapeutics is using digital technology to deliver safe and effective treatments to patients. Digital therapeutics, a term created by Click, refers to mobile software applications that treat a disease or condition. Like other therapeutics, digital therapeutics go through clinical trials before application. Click is developing digital therapeutics to be used independently or in conjunction with biomedical treatments for a variety of indications. This is achieved through cognitive and neurobehavioural mechanisms and their Clickometrics data science platform to personalize user experience. Click’s first product, Clickotine, is already in use as a digital smoking cessation program. Other products are in development for depression, insomnia and schizophrenia.